Concepedia
Statistics
Publications
5
Citations
1K
H-Index
Active since
2009
Affiliations
University of Pennsylvania(Current)
Translational Therapeutics (United States)
Parker Institute for Cancer Immunotherapy
Merck & Co., Inc., Rahway, NJ, USA (United States)
Mary Carberry is an author at University of Pennsylvania specializing in oncology, medicine, and cancer immunotherapy.
Publications per year
2009–2022
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
Alexander C. Huang, Robert Orlowski, Xiaowei Xu et al. · Nature Medicine · 2019 · 702 citations
Medicine, Clinical Sciences, Oncology +17
Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers
Josephine R. Giles, Sasikanth Manne, Elizabeth Freilich et al. · Immunity · 2022 · 122 citations · Full text
Life Sciences, Bioinformatics, Molecular Biology +14
Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases
Ravi K. Amaravadi, Lynn M. Schuchter, David F. McDermott et al. · Clinical Cancer Research · 2009 · 115 citations · Full text
Medicine, Oncology, Pharmacology +17
A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma
Davendra Sohal, Kristine Mykulowycz, Takeshi Uehara et al. · Annals of Oncology · 2013 · 89 citations · Full text
Medicine, Oncology, Pharmacology +14
Abstract CT181: Safety, activity, and biomarkers for neoadjuvant anti-PD-1 therapy in melanoma
Alexander C. Huang, Xiowei Xu, Robert Orlowski et al. · Cancer Research · 2018 · 13 citations
Life Sciences, Immunology, Oncology +17
1–5 of 5